Philip Ward

The European Medicines Agency (EMA), along with the Heads of Medicines Agencies (HMA), have published the ‘EU Medicines Agencies Network Strategy to 2020.

The results from the first Phase 1 trial of an Ebola vaccine based on the current (2014) strain of the virus have been published in The Lancet.

Christa Wirthumer-Hoche, PhD, head of the Austrian Medicines and Medical Devices Agency, has been elected Vice-Chair of the European Medicines Agency (EMA) by the Management Board for a three-year period.

To celebrate 20 years since its opening, the European Medicines Agency (EMA) organized a one-day meeting this week. Called “Science, Medicines, Health: Patients at the heart of future innovation”, the invitation-only event in London focused on the EMA’s future role

The European Forum for GCP has postponed its multi-stakeholder workshop about “Excluded Older People from Clinical Research,” which was due to be held on 24 March at the Faculty of Medicine/Hospital Clínic de Barcelona, Spain.

A new provider of clinical studies and strategic consulting, Orange OTC Research, aims to shake up the market for over-the-counter (OTC) medicines and related products.

Efforts are escalating to encourage sponsors, research institutions, and clinical investigators to accept oversight for multi-center studies by central institutional review boards (IRBs), as seen in several discussions of this topic at the December conference on "Advancing Ethical Research" sponsored by Public Responsibility in Medicine & Research.

The EuroMeeting and Clinical Forum will take place in Paris as planned, in spite of January’s terrorist attacks in the French capital.

Françoise Meunier will become Director of Special Projects for the European Organization for Research and Treatment of Cancer starting April 1, 2015.

The European Forum for GCP (EFGCP) Geriatric Medicines Working Party is organizing a multi-stakeholder workshop, “Excluded Older People from Clinical Research”

EUCROF has unveiled proposals on the early publication of clinical trial information.

Pharmaceutical companies took advantage of East Germany's financial problems, report found.

The Clinical Research Infrastructure Initiative will benefit from additional funding from the UK government

In the battle against Ebola, incentives from governments and healthcare policymakers have been and will continue to be vital...

New Oncology has entered into a research agreement with Gustave Roussy Cancer Campus in Paris.

During the first six months of 2014, the number of scientific advice and protocol assistance requests for human medicines received by the EMA increased by 16%

The Alliance for Clinical Research Excellence and Safety (ACRES) has opened its first national affiliate, ACRES Japan, in Tokyo. Fumimaro Takaku, M.D., president of the Japanese Association of Medical Sciences, will act as president of the board of directors, and ACRES Japan will provide a model for the organization?s planned network of national affiliates.

Leading international experts are organizing a new high-level two-day meeting about the interdisciplinary challenges faced in pediatric drug development. The plan is for the meeting to become an annual event. Called ?Development of Medicines for Paediatric and Rare Diseases,? the conference will take place in Basel, Switzerland, on?February 3-4, 2015

A Medical Technology Working Party is established to promote collaboration and dialogue on the specific aspects of clinical standards.

IACRN and ACRES have created a strategic alliance agreement.

Cloud technology is enabling more clinical trial sponsors to meet health authorities' increasing demands for trial master file accessibility and completeness.

A Polish legal expert and the German/Canadian President of the European Federation of Pharmaceutical Industries and Associations will be the co-chairs of the next Drug Information Association EuroMeeting.

ICR has announced two new courses for December 2014 about the impact of the European Union regulation and essential line management.

Fujitsu and ACRES have linked up to address challenges facing the development of medicines and health-related research endeavors.

The European Forum for Good Clinical Practice says proposed restrictive access to clinical data would impede further progress in health research.

Synexus has opened a research center in Bochum.

ESMO is concerned that the proposed European Union General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.

EMA has postponed formal adoption of the policy on publication of clinical trial data until its October 2, 2014 meeting

Progress on new research and treatments for dementia has been "achingly slow," noted Dennis Gillings, PhD, Executive Chairman of Quintiles.

Future growth could be impacted by a marked skills shortage, according to a survey from Berkley Group.